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Veno-venous extracorporeal membrane oxygenation in 
pregnancy: does foetal viability matter?
With the increasing use of extracorporeal membrane 
oxygenation for adults with acute hypoxic respiratory failure, 
the indications for its use have expanded1. We wanted to 
share the results of a recent case from our institution, of a 
woman who experienced respiratory failure secondary to 
hyperemesis gravidarum (HG). HG is a rare complication 
of pregnancy (0.3% to 2.0% of pregnancies), resulting 
in uncontrolled or excessive nausea and vomiting with 
dehydration and weight loss, typically in the first to mid 
second trimester, and is a diagnosis of exclusion2. 
HG can result in negative maternal and foetal outcomes. 
Mothers with HG are more likely to develop emotional 
dysfunction and malnutrition, and even rarely end-organ 
damage and death. A single case report described a case of 
HG leading to diaphragmatic rupture3. Additionally, foetal 
complications include: low birth weight, preterm birth, and 
small-for-gestational-age neonates2,4. In our case, we describe 
the first documented case of aspiration pneumonitis resulting 
in acute respiratory distress syndrome (ARDS) and hypoxic 
respiratory failure requiring extracorporeal membrane 
oxygenation (ECMO). 
A 25-year-old G2P1 woman with type 1 diabetes mellitus, 
pregnancy-induced hypertension, and gastroparesis, 
presented at 21 weeks gestation to an outside hospital 
with nausea and vomiting. She developed acute hypoxic 
respiratory failure, which required transfer to our institution. 
Upon presentation, she was tachypnoeic and tachycardic and 
chest examination revealed diffuse rales and wheeze. She was 
clinically hypoxic and a chest radiograph revealed bilateral 
pulmonary infiltrates consistent with aspiration pneumonitis. 
Both conventional and non-conventional (high-flow oscillatory 
and airway pressure release) ventilatory strategies failed.  
This failure resulted in increasing hypoxaemia despite a 
positive end-expiratory pressure of >17 cmH2O, chemical 
paralysis, and FiO2 of 100%, with oxygen saturation of 
between 80% and 85%. Her arterial blood gas revealed  
a pH of 7.17, PaCO2 31 mmHg, PaO2 43 mmHg, HCO3  
14.2 mmol/l, base deficit  -11.6, and O2 saturation of 83.6%  
(PaO2/FiO2 ratio 43). The patient was placed on veno-venous 
ECMO (VV ECMO) on hospital day one with a 23 Fr cannula 
in the right femoral vein and a 21 Fr arterial cannula in the 
right internal jugular vein. Heparin anticoagulation was 
started after an initial pre-cannulation bolus of 50 units/kg 
to maintain an activated coagulation time of between 160 
and 180 seconds. Conventional ventilation was reinstituted 
with rest ventilator settings (pressure controlled ventilation, 
rate 10 /minute, positive end-expiratory pressure 10 cmH2O, 
delta 20 cmH2O with peak inspiratory pressure 30 cmH2O). 
Flexible bronchoscopy confirmed aspiration with mucosal 
hyperaemia and some food particles. Broncho-alveolar 
lavage was performed. As part of our VV ECMO management 
strategy in pregnancy, we increased her sweep gas to achieve 
PaCO2 between 30 and 35 mmHg to aid the diffusion of 
blood gases between the foetal and maternal circulations 
and a greater potential for oxygen–haemoglobin dissociation 
during pregnancy, thus facilitating oxygen delivery across 
the placenta. There were no haemorrhagic or obstetric 
complications during the ECMO run. She was decannulated 
on VV ECMO day 6. The patient was discharged on post–VV 
ECMO day 13 and her cognitive evaluation revealed no 
deficits. She returned to our hospital at 26 weeks gestation 
with a non-reassuring foetal heart rate pattern. The child was 
delivered by uncomplicated caesarean section. The neonatal 
period was complicated by respiratory distress of prematurity; 
subsequently, the child was growing appropriately without 
any evidence of neurodevelopmental delay.
While there is a single published report of a pregnant 
woman with status asthmaticus and a pre-viable foetus 
that survived to birth1, there are no published reports of 
ARDS in the gravid patient due to aspiration pneumonitis 
from HG. The majority of published reports of the use of 
ECMO during pregnancy are related to H1N1 pneumonia5. 
Previous reports have focused on single cases or small series 
of pregnant women requiring ECMO, with only a few cases 
of preterm infants in gravid ECMO patients1,5. Some of these 
preterm infants were stillborn, and other pregnancies were 
terminated in hopes that medical termination of pregnancy 
would improve the maternal outcome, to avoid potential 
bleeding complications, or for evidence of hypoxic injury to 
the foetus5,6. This case demonstrates that in the absence 
of a specific indication, medical termination of pregnancy 
may introduce the risks of procedural complications such as 
bleeding, infection, injury or medicinal effects such as drug 
reaction, allergy, or drug interactions, without providing 
protective benefits to the mother. This is the first case that 
we were able to identify in which the mother of a preterm 
infant was placed on ECMO support for ARDS due to 
aspiration pneumonitis, and then went on to carry the foetus 
to viability, deliver, and have follow-up data on maternal and 
foetal outcome. These circumstances make this case a unique 
addition to the literature. This case raises the possibility that 
appropriately selected gravid patients with a pre-viable foetus 
with ARDS may benefit from VV ECMO support, and that the 
need for VV ECMO is not an absolute indication for medical 
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